The appeal of antioxidants hinges in part on the notion that they are less likely to have side effects than standard pharmaceutical treatments, but this idea has been called into question over the years.
Today, dietary supplement use is increasingly prevalent among patients with autism, but caregivers seeking to take advantage these therapies need to consider their options carefully to find an effective and safe solution.
In light of growing evidence, researchers are now considering the endocannabinoid system as a possible target for future therapeutics that treat social anxiety in patients with autism.
Dr. Slattery discusses the value of his new diagnostic test as well as his views on the most promising developments in the field and how they might be used to reduce the impact of autism worldwide.
Nutritional supplements with antioxidant and/or anti-inflammatory properties, including curcumin and quercetin, may potentially alleviate stimming in patients with autism.
Recent research connects propionic acidemia to the pathogenesis of ASD, opening up a new subfield of clinical research that has the potential to immediately help patients find relief from symptoms.
Treatment for aggressive behavior in patients with autism has historically been elusive, but new research suggests that treating sleep problems may be the key to symptom relief.
Emerging research suggests that autism-associated behavioral abnormalities are modulated by gut physiology, and dietary supplements like probiotics and short chain fatty acids may prove to be effective therapeutic options.
Alternative treatments for autism gives clinicians, parents, and patients new opportunities for creating symptom relief, but any treatment strategy must be tailored to the unique needs of each individual.
A recently-developed blood-based peripheral marker that can be used to identify autism-associated ileocolitis could help clinicians develop more effective, patient-specific strategies for symptom management.